Sponsors (89)
Need help making sense of this bill?
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced May 22, 2023 by Cathy McMorris Rodgers · Last progress May 22, 2023
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Increasing Transparency in Generic Drug Applications Act
Drug Price Transparency in Medicaid Act of 2023
Promoting Transparency and Healthy Competition in Medicare Act
Diagnostic Lab Testing Transparency Act
Referred to the Subcommittee on Health.
Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
Committee Consideration and Mark-up Session Held.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
